Breaking News

IPS Appoints Bigelow to Board

November 7, 2012

Bigelow joins Lavin as external member

IPS-Integrated Project Services has appointed two new members to its board of directors, Peter T. Bigelow and Cliff Lavin. Mr. Bigelow is the chief executive officer of xCell Strategic Consulting, a global strategic development and operations improvement solutions firm. He previously served as president for North America Commercial Operations at Patheon and also held the position of interim chief executive officer at the company. Prior to joining Patheon, Mr. Bigelow held leadership roles with increasing responsibilities for global operations with Wyeth.
“Peter and Cliff both bring proven management expertise, outstanding business acumen and a wide-range of experience to IPS”, said Dave Goswami, PE, chief executive officer and managing director of IPS. “Peter’s knowledge of the biopharmaceutical industry and Cliff’s business acumen will be of tremendous value as we continue to develop our short- and long-term plans. Peter is an industry recognized, experienced Fortune 500 executive with extensive global experience and has a true understanding of the issues facing global biopharmaceutical manufacturing companies in the U.S. and emerging countries. Cliff has executive experience in global industries not related to biopharmaceuticals. We believe that the diverse experiences of Peter and Cliff will be an invaluable asset as our growth takes us to uncharted territory.”

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016